PMC:7600245 / 3102-3534
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T4 | 173-181 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T19 | 328-336 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T8 | 286-289 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T9 | 412-415 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T7 | 69-84 | Chemical | denotes | antiviral drugs | http://purl.obolibrary.org/obo/CHEBI_36044 |
| T8 | 69-78 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T9 | 79-84 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T10 | 96-119 | Chemical | denotes | anti-inflammatory drugs | http://purl.obolibrary.org/obo/CHEBI_35472 |
| T11 | 114-119 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T12 | 124-137 | Chemical | denotes | anticoagulant | http://purl.obolibrary.org/obo/CHEBI_50249 |
| T13 | 138-143 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T14 | 275-285 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T15 | 400-411 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 173-187 | Phenotype | denotes | cytokine storm | http://purl.obolibrary.org/obo/HP_0033041 |
| T2 | 196-210 | Phenotype | denotes | coagulopathies | http://purl.obolibrary.org/obo/HP_0003256 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T25 | 230-386 | Sentence | denotes | Considering the current clinical guidelines, remdesivir has been recommended for the treatment of COVID-19 in hospitalized patients with severe disease [9]. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 55 | 196-210 | Disease | denotes | coagulopathies | MESH:D001778 |
| 65 | 353-361 | Species | denotes | patients | Tax:9606 |
| 67 | 275-285 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 68 | 400-411 | Chemical | denotes | favipiravir | MESH:C462182 |
| 71 | 328-336 | Disease | denotes | COVID-19 | MESH:C000657245 |